Arena Pharmaceuticals ? One Huge Step Forward, But Many More Remain (ARNA, VVUS, OREX)

Posted on June 28, 2012 at 15:40 PM EDT

ARNA shareholders got some major validation on June 27, 2012, when the company announced that the FDA had formally approved the company's weight-loss drug, Belviq (aka lorcaserin). But, Arena's battle is only beginning.

Related Stocks:

Arena Pharmaceuticals, Inc. Orexigen Therapeutics, Inc. Vivus, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates